Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Ptc Therapeutics (PTCT) Other Gross PP&E Adjustments (2016 - 2025)

Ptc Therapeutics has reported Other Gross PP&E Adjustments over the past 14 years, most recently at $22.3 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $22.3 million for Q4 2025, down 40.73% from a year ago — trailing twelve months through Dec 2025 was $22.3 million (down 40.73% YoY), and the annual figure for FY2025 was $22.3 million, down 40.73%.
  • Other Gross PP&E Adjustments for Q4 2025 was $22.3 million at Ptc Therapeutics, up from -$90.0 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for PTCT hit a ceiling of $44.2 million in Q4 2023 and a floor of -$217.8 million in Q1 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$91.5 million (2021), compared with a mean of -$84.8 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 387.22% in 2021 and later skyrocketed 897.09% in 2023.
  • Ptc Therapeutics' Other Gross PP&E Adjustments stood at -$1.2 million in 2021, then soared by 466.53% to $4.4 million in 2022, then skyrocketed by 897.09% to $44.2 million in 2023, then dropped by 14.88% to $37.6 million in 2024, then crashed by 40.73% to $22.3 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $22.3 million (Q4 2025), -$90.0 million (Q3 2025), and -$65.5 million (Q2 2025) per Business Quant data.